The recent overhaul of US childhood vaccine policy has triggered widespread criticism from health experts and organizations, raising alarms about the erosion of evidence-based standards and the potential risks to vulnerable populations. This controversy is reverberating internationally, with Canadian officials questioning the reliability of US health institutions and states reaffirming their commitment to science. Meanwhile, advances in climate action and biomedical research offer a counterpoint of optimism amid the turmoil.
Bluesky
#public health
#vaccines
#science policy
#climate action
#medical innovation
